Head & Neck/Thyroid Cancers
News
Excess cancer deaths predicted as care is disrupted by COVID-19
Conference Coverage
Antitumor treatment may increase risk of severe events in COVID-19 patients
Article
ASCO panel outlines cancer care challenges during COVID-19 pandemic
Article
Will coronavirus restrictions lead to more advanced cancers?
News
European cancer centers restructure care in the era of COVID-19
News
Want to keep cancer patients and providers safe during the pandemic? Here’s how
Prescreening, telemedicine, and limited interventions top the list of best practices for patients, while PPE, telecommuting, and wellness/stress...
News
Cancer patients report delays in treatment because of COVID-19
Half of survey respondents in active treatment reported changes, delays, or disruptions to care.
News
Cancer care ‘transformed in space of a month’ because of pandemic
Changes brought about by COVID-19 may endure after the pandemic is over.
News
ASCO announces its own COVID-19 and cancer registry
ASCO aims to learn how COVID-19 is impacting cancer patients’ treatment and outcomes.
News
Cancer prevalence among COVID-19 patients may be higher than previously reported
A meta-analysis suggests the cancer prevalence among COVID-19 patients is 2%, not 1% as previously reported.
